Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

Globus Medical has gained 59.3% since the start of ... One industry peer that looks good is Penumbra, Inc. (PEN). PEN has a Zacks Rank of # 2 (Buy) and a Value Score of C, a Growth Score of ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Penumbra (PEN – Research Report) today and set a price target of $305.00. The company’s ...

Penumbra (NYSE:PEN) is preparing to release its quarterly ... on the analyst ratings and average 1-year price targets of Globus Medical, Hologic and Masimo, three prominent industry players ...

The renowned medical device company has a market capitalization ... with the industry’s 14.5% growth over the past year. PEN’s earnings surpassed estimates in three of the trailing four ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...